Neuraxpharm steps into the Digital Health market with a wearable device developed by mjn-neuro that provides an early warning of epileptic seizures
The CNS specialist Neuraxpharm has signed a commercialisation agreement with mjn-neuro with exclusivity in Europe
DÜSSELDORF, Germany, Oct. 25, 2022 /PRNewswire/ — Neuraxpharm Group (Neuraxpharm), …